CAVU Biotherapies
PrivateLast Round
Debt
Mar 4, 2019
Total Funding Raised
$50,000
Company Overview
CAVU Biotherapies is a biotechnology company that develops personalized immune-based therapies for the treatment of cancer and autoimmune diseases in pets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CAVU Biotherapies Comparables
Compare CAVU Biotherapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ELIAS Animal Health | 93% | |
| Torigen Pharmaceuticals, Inc. | 85% | |
| FidoCure | 79% | |
CAVU Biotherapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 4, 2019 |
CAVU Biotherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Factory | Accelerator |
| Houston Angel Network | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2019
$50K debt round closed.
CAVU Biotherapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CAVU Biotherapies's valuation, stock price, and market status.